Haemonetics Corporation (NYSE:HAE) Q1 2024 Earnings Conference Call August 8, 2023 8:00 AM ET

Company Participants

Olga Guyette - Senior Director-Investor Relations & Treasury

Christopher Simon - President and Chief Executive Officer

James D'Arecca - Executive Vice President and Chief Financial Officer

Conference Call Participants

Anthony Petrone - Mizuho Americas

Mike Matson - Needham & Company

Andrew Cooper - Raymond James

Joanne Wuensch - Citi

Michael Petusky - Barrington Research

Larry Solow - CJS Securities

David Turkaly - JMP Securities

Operator

Good morning and thank you for standing by. Welcome to the First Quarter 2024 Haemonetics Corporation's Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Olga Guyette, Senior Director, Investor Relations & Treasury. Please go ahead.

Olga Guyette

Good morning, everyone. Thank you for joining us for Haemonetics first quarter fiscal 2024 conference call and webcast. I'm joined today by Chris Simon, our CEO; and James D'Arecca, our CFO.

This morning, we posted our first fiscal 2024 results to our Investor Relations website, along with our updated fiscal 2024 guidance.

Before we begin, just a quick reminder that all revenue growth rates discussed today are organic and exclude the impact of currency fluctuations. We'll also refer to other non-GAAP financial measures to help investors understand Haemonetics' ongoing business performance. Please note that these measures exclude certain charges and income items. For a full list of excluded items, reconciliations are GAAP results and comparisons with the prior year periods, please refer to our first quarter fiscal 2024 earnings release available in our website.

Our remarks today include forward-looking statements, and our actual results may differ materially from the anticipated results. Factors that may cause our results to differ include those referenced in the Safe Harbor statement in today's release and in our other SEC filings. We do not undertake any obligation to update these forward-looking statements.

And now, I'd like to turn it over to Chris.

Christopher Simon

Thanks Olga. Good morning and thank you all for joining. Today, we reported first quarter organic revenue growth of 21%, and adjusted earnings per diluted share of $1.05, 81% growth over prior year. It was a particularly strong start to the year with market leading performance across our businesses, delivering revenue growth and adjusted operating margin expansion, while advancing meaningful innovation and commercial milestones.